A detailed history of Values First Advisors, Inc. transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Values First Advisors, Inc. holds 2,697 shares of DVAX stock, worth $34,144. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,697
Previous 17,370 84.47%
Holding current value
$34,144
Previous $195,000 84.62%
% of portfolio
0.02%
Previous 0.12%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$10.05 - $11.61 $147,463 - $170,353
-14,673 Reduced 84.47%
2,697 $30,000
Q2 2024

Jul 19, 2024

SELL
$10.73 - $12.58 $72,427 - $84,915
-6,750 Reduced 27.99%
17,370 $195,000
Q1 2024

Apr 23, 2024

BUY
$11.7 - $14.98 $282,204 - $361,317
24,120 New
24,120 $299,000

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.6B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Values First Advisors, Inc. Portfolio

Follow Values First Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Values First Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Values First Advisors, Inc. with notifications on news.